GB9109506D0 - Therapeutic nucleosides - Google Patents
Therapeutic nucleosidesInfo
- Publication number
- GB9109506D0 GB9109506D0 GB919109506A GB9109506A GB9109506D0 GB 9109506 D0 GB9109506 D0 GB 9109506D0 GB 919109506 A GB919109506 A GB 919109506A GB 9109506 A GB9109506 A GB 9109506A GB 9109506 D0 GB9109506 D0 GB 9109506D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- therapeutic nucleosides
- nucleosides
- therapeutic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Virology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Molecular Biology (AREA)
- Epidemiology (AREA)
- Gastroenterology & Hepatology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Priority Applications (14)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB919109506A GB9109506D0 (en) | 1991-05-02 | 1991-05-02 | Therapeutic nucleosides |
ZA923185A ZA923185B (en) | 1991-05-02 | 1992-04-30 | Therapeutic nucleosides |
MYPI92000749A MY137298A (en) | 1991-05-02 | 1992-04-30 | Therapeutic nucleosides |
PT100435A PT100435B (en) | 1991-05-02 | 1992-04-30 | THERAPEUTIC NUCLEOSIDES |
CA002102120A CA2102120A1 (en) | 1991-05-02 | 1992-05-01 | Use of a 1,3-oxathlolan derivative for the treatment of hepatitis b infection |
IL101757A IL101757A0 (en) | 1991-05-02 | 1992-05-01 | Pharmaceutical compositions containing a 1,3-oxathiolane analogue |
UA93004171A UA37251C2 (en) | 1991-05-02 | 1992-05-01 | Substance for treatment and prevention of viral hepatitis b and method for treating viral hepatitis b |
PCT/GB1992/000803 WO1992019246A1 (en) | 1991-05-02 | 1992-05-01 | Use of a 1,3-oxathiolan derivative for the treatment of hepatitis b infection |
JP4508657A JPH06506929A (en) | 1991-05-02 | 1992-05-01 | Use of 1,3-oxathiolane derivatives for the treatment of hepatitis B virus infection |
RU93058325A RU2104700C1 (en) | 1991-05-02 | 1992-05-01 | Method of hepatitis b treatment |
EP92908933A EP0583274A1 (en) | 1991-05-02 | 1992-05-01 | Use of a 1,3-oxathiolan derivative for the treatment of hepatitis b infection |
AU16620/92A AU1662092A (en) | 1991-05-02 | 1992-05-01 | Use of a 1,3-oxathiolan derivative for the treatment of hepatitis b infection |
MX9203214A MX9203214A (en) | 1991-05-02 | 1992-06-24 | THERAPEUTIC NUCLEOSIDES. |
IE136392A IE921363A1 (en) | 1991-05-02 | 1992-07-01 | Therapeutic nucleosides |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB919109506A GB9109506D0 (en) | 1991-05-02 | 1991-05-02 | Therapeutic nucleosides |
Publications (1)
Publication Number | Publication Date |
---|---|
GB9109506D0 true GB9109506D0 (en) | 1991-06-26 |
Family
ID=10694346
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB919109506A Pending GB9109506D0 (en) | 1991-05-02 | 1991-05-02 | Therapeutic nucleosides |
Country Status (14)
Country | Link |
---|---|
EP (1) | EP0583274A1 (en) |
JP (1) | JPH06506929A (en) |
AU (1) | AU1662092A (en) |
CA (1) | CA2102120A1 (en) |
GB (1) | GB9109506D0 (en) |
IE (1) | IE921363A1 (en) |
IL (1) | IL101757A0 (en) |
MX (1) | MX9203214A (en) |
MY (1) | MY137298A (en) |
PT (1) | PT100435B (en) |
RU (1) | RU2104700C1 (en) |
UA (1) | UA37251C2 (en) |
WO (1) | WO1992019246A1 (en) |
ZA (1) | ZA923185B (en) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5684164A (en) * | 1988-04-11 | 1997-11-04 | Biochem Pharma Inc. | Processes for preparing substituted 1,3-oxathiolanes with antiviral properties |
US5466806A (en) * | 1989-02-08 | 1995-11-14 | Biochem Pharma Inc. | Processes for preparing substituted 1,3-oxathiolanes with antiviral properties |
IL100502A (en) * | 1991-01-03 | 1995-12-08 | Iaf Biochem Int | Pharmaceutical compositions containing cis-4-amino-1(hydroxymethyl-1,3-oxathiolan-5-yl)-1H-pyrimid-2-one nucleoside or its derivatives |
GB9110874D0 (en) * | 1991-05-20 | 1991-07-10 | Iaf Biochem Int | Medicaments |
ZA923640B (en) * | 1991-05-21 | 1993-02-24 | Iaf Biochem Int | Processes for the diastereoselective synthesis of nucleosides |
TR200102501T2 (en) | 1998-12-23 | 2002-01-21 | Shire Biochem Inc. | Antiviral nucleoside analogs. |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5159067A (en) * | 1987-01-28 | 1992-10-27 | University Of Georgia Research Foundation Inc. | 5'-Diphosphohexose nucleoside pharmaceutical compositions |
US5047407A (en) * | 1989-02-08 | 1991-09-10 | Iaf Biochem International, Inc. | 2-substituted-5-substituted-1,3-oxathiolanes with antiviral properties |
JPH04501854A (en) * | 1989-05-15 | 1992-04-02 | アメリカ合衆国 | How to treat hepatitis |
US5204466A (en) * | 1990-02-01 | 1993-04-20 | Emory University | Method and compositions for the synthesis of bch-189 and related compounds |
-
1991
- 1991-05-02 GB GB919109506A patent/GB9109506D0/en active Pending
-
1992
- 1992-04-30 MY MYPI92000749A patent/MY137298A/en unknown
- 1992-04-30 PT PT100435A patent/PT100435B/en not_active IP Right Cessation
- 1992-04-30 ZA ZA923185A patent/ZA923185B/en unknown
- 1992-05-01 EP EP92908933A patent/EP0583274A1/en not_active Withdrawn
- 1992-05-01 UA UA93004171A patent/UA37251C2/en unknown
- 1992-05-01 JP JP4508657A patent/JPH06506929A/en active Pending
- 1992-05-01 CA CA002102120A patent/CA2102120A1/en not_active Abandoned
- 1992-05-01 RU RU93058325A patent/RU2104700C1/en active
- 1992-05-01 IL IL101757A patent/IL101757A0/en unknown
- 1992-05-01 AU AU16620/92A patent/AU1662092A/en not_active Abandoned
- 1992-05-01 WO PCT/GB1992/000803 patent/WO1992019246A1/en not_active Application Discontinuation
- 1992-06-24 MX MX9203214A patent/MX9203214A/en unknown
- 1992-07-01 IE IE136392A patent/IE921363A1/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
AU1662092A (en) | 1992-12-21 |
IL101757A0 (en) | 1992-12-30 |
EP0583274A1 (en) | 1994-02-23 |
MY137298A (en) | 2009-01-30 |
PT100435B (en) | 1999-08-31 |
UA37251C2 (en) | 2001-05-15 |
MX9203214A (en) | 1992-07-01 |
PT100435A (en) | 1993-09-30 |
CA2102120A1 (en) | 1992-11-03 |
IE921363A1 (en) | 1992-11-04 |
JPH06506929A (en) | 1994-08-04 |
RU2104700C1 (en) | 1998-02-20 |
ZA923185B (en) | 1993-11-01 |
WO1992019246A1 (en) | 1992-11-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA894837B (en) | Therapeutic nucleosides | |
EP0434450A3 (en) | Therapeutic nucleosides | |
GB9105899D0 (en) | Therapeutic nucleosides | |
EP0356166A3 (en) | Therapeutic nucleosides | |
GB9200150D0 (en) | Therapeutic nucleosides | |
ZA923185B (en) | Therapeutic nucleosides | |
GB8823353D0 (en) | Therapeutic nucleosides | |
EP0442757A3 (en) | Therapeutic nucleosides | |
GB8912972D0 (en) | Therapeutic nucleosides | |
GB9104741D0 (en) | Therapeutic nucleosides | |
GB9109505D0 (en) | Therapeutic nucleosides | |
GB9105028D0 (en) | Therapeutic nucleosides | |
AU2641192A (en) | Therapeutic nucleosides | |
GB9016775D0 (en) | Therapeutic nucleosides | |
GB9214171D0 (en) | Therapeutic nucleosides | |
GB9214170D0 (en) | Therapeutic nucleosides | |
GB9214172D0 (en) | Therapeutic nucleosides | |
GB9220317D0 (en) | Therapeutic nucleosides | |
GB9223178D0 (en) | Therapeutic nucleosides | |
GB9208017D0 (en) | Therapeutic nucleosides | |
GB9223181D0 (en) | Therapeutic nucleosides | |
GB9204026D0 (en) | Therapeutic nucleosides | |
GB9203307D0 (en) | Therapeutic nucleosides | |
GB9223180D0 (en) | Therapeutic nucleosides | |
GB9220156D0 (en) | Therapeutic nucleosides |